-
1
-
-
85120238866
-
-
Food and Drug Administration Nonprescription Drug Advisory Committee. Meeting agenda and briefing information for May 11, 2001. Available at: www.fda.gov/ohrms/dockets/ac/cder01.html#Nonprescription. Accessed March 28, 2001.
-
-
-
-
2
-
-
85120188499
-
-
Cauchon D. Why allergy drugs cost so much. USA Today. April 12, 2000:A1.
-
-
-
-
3
-
-
85120186834
-
Sedating antihistamines impair children’s ability to learn
-
D. Cauchon Sedating antihistamines impair children’s ability to learn April 12 USA Today 2000 A5
-
(2000)
USA Today
, pp. A5
-
-
Cauchon, D.1
-
4
-
-
85120184557
-
“Complex issues” require much study before action, FDA says
-
D. Cauchon “Complex issues” require much study before action, FDA says April 12 USA Today. 2000 A5
-
(2000)
USA Today.
, pp. A5
-
-
Cauchon, D.1
-
5
-
-
32644483701
-
The drug approval process in the U.S., Europe, and Japan
-
I.M. Vilas-Boas C.P. Tharp The drug approval process in the U.S., Europe, and Japan J Manage Care Pharm 3 1997 459 465
-
(1997)
J Manage Care Pharm
, vol.3
, pp. 459-465
-
-
Vilas-Boas, I.M.1
Tharp, C.P.2
-
6
-
-
85120211397
-
-
Nordenberg T. Now available without a prescription. FDA Consumer Magazine [online]. November 1996. Available at: www.fda.gov/fdac/features/996_otc.html. Accessed March 28, 2001.
-
-
-
-
7
-
-
0031024417
-
A cost of illness study of allergic rhinitis in the United States
-
D.C. Malone K.A. Lawson D.H. Smith A cost of illness study of allergic rhinitis in the United States J Allergy Clin Immunol. 99 1997 22 27
-
(1997)
J Allergy Clin Immunol.
, vol.99
, pp. 22-27
-
-
Malone, D.C.1
Lawson, K.A.2
Smith, D.H.3
-
8
-
-
0029819481
-
Learning impairment and allergic rhinitis
-
F.E. Simons Learning impairment and allergic rhinitis Allergy Asthma Proc. 17 1996 185 189
-
(1996)
Allergy Asthma Proc.
, vol.17
, pp. 185-189
-
-
Simons, F.E.1
-
9
-
-
0033162925
-
Complications of allergic rhinitis
-
R.A. Settipane Complications of allergic rhinitis Allergy Asthma Proc. 20 1999 209 213
-
(1999)
Allergy Asthma Proc.
, vol.20
, pp. 209-213
-
-
Settipane, R.A.1
-
10
-
-
0030445520
-
Clinical consequences of histamine H1-receptor antagonist drugs
-
1-receptor antagonist drugs J Allergy Clin Immunol. 98 1996 307 318
-
(1996)
J Allergy Clin Immunol.
, vol.98
, pp. 307-318
-
-
Du Buske, L.M.1
-
11
-
-
0030894778
-
Sedative effects of antihistamines: safety, performance, learning, and quality of life
-
T.M. Nolen Sedative effects of antihistamines: safety, performance, learning, and quality of life Clin Ther. 19 1997 39 55
-
(1997)
Clin Ther.
, vol.19
, pp. 39-55
-
-
Nolen, T.M.1
-
12
-
-
14444276731
-
Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance
-
G.G. Kay B. Berman S.H. Mockoviak Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance Arch Intern Med. 157 1997 2350 2356
-
(1997)
Arch Intern Med.
, vol.157
, pp. 2350-2356
-
-
Kay, G.G.1
Berman, B.2
Mockoviak, S.H.3
-
14
-
-
0023322164
-
Psychomotor effects of astemizole and chlorpheniramine, alone and in combination with alcohol
-
I. Hindmarch J.Z. Bhatti Psychomotor effects of astemizole and chlorpheniramine, alone and in combination with alcohol Int Clin Psychopharmacol. 2 1987 117 119
-
(1987)
Int Clin Psychopharmacol.
, vol.2
, pp. 117-119
-
-
Hindmarch, I.1
Bhatti, J.Z.2
-
15
-
-
85120204332
-
-
National Transportation Safety Board. Testimony of NTSB Chairman Jim Hall for the record for the Committee on Commerce, Science, and Transportation Subcommittee on Surface Transportation and Merchant Marine, United States Senate, regarding S. 1501, the Motor Carrier Safety Improvement Act of 1999. September 29, 1999. Available at: www.ntsb.gov/speeches/jhc990929.htm. Accessed March 28, 20
-
-
-
-
16
-
-
0026357678
-
Comparative safety of H1 antihistamines
-
1 antihistamines Ann Allergy. 67 1991 625 633
-
(1991)
Ann Allergy.
, vol.67
, pp. 625-633
-
-
Meltzer, E.O.1
-
17
-
-
0034090862
-
Effects of fexofenadine, diphenhydramine, and alcohol on driving performance
-
J.M. Weiler J.R. Bloomfield G.G. Woodworth Effects of fexofenadine, diphenhydramine, and alcohol on driving performance Ann Intern Med. 132 2000 354 363
-
(2000)
Ann Intern Med.
, vol.132
, pp. 354-363
-
-
Weiler, J.M.1
Bloomfield, J.R.2
Woodworth, G.G.3
-
18
-
-
0025360319
-
Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator
-
F.M. Gengo C. Gabos L. Mechtler Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator Ann Allergy. 64 1990 520 526
-
(1990)
Ann Allergy.
, vol.64
, pp. 520-526
-
-
Gengo, F.M.1
Gabos, C.2
Mechtler, L.3
-
19
-
-
0029073094
-
Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989–94
-
J.F. O’Hanlon J.G. Ramaekers Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989–94 Allergy. 50 1995 234 242
-
(1995)
Allergy.
, vol.50
, pp. 234-242
-
-
O’Hanlon, J.F.1
Ramaekers, J.G.2
-
20
-
-
0343203273
-
Digest of State Alcohol-Highway Safety Related Legislation
-
National Highway Traffic Safety Administration Digest of State Alcohol-Highway Safety Related Legislation 15th ed. 1996 U.S. Department of Transportation Washington, DC
-
(1996)
-
-
National Highway Traffic Safety Administration1
-
23
-
-
0027194790
-
Seasonal allergic rhinitis and antihistamine effects on children’s learning
-
E.F.P.M. Vuurman L.M.A. van Veggel M.M.C. Uiterwijk Seasonal allergic rhinitis and antihistamine effects on children’s learning Ann Allergy. 71 1993 121 126
-
(1993)
Ann Allergy.
, vol.71
, pp. 121-126
-
-
Vuurman, E.F.P.M.1
van Veggel, L.M.A.2
Uiterwijk, M.M.C.3
-
24
-
-
0032784403
-
Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood, and sedation
-
G.G. Kay A.G. Harris Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood, and sedation Clin Exp Allergy 29 suppl 3 1999 147 150
-
(1999)
Clin Exp Allergy
, vol.29
, Issue.suppl 3
, pp. 147-150
-
-
Kay, G.G.1
Harris, A.G.2
-
25
-
-
0031789449
-
Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
-
M.S. Dykewicz S. Fineman Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology Ann Allergy Asthma Immunol. 81 1998 478 518
-
(1998)
Ann Allergy Asthma Immunol.
, vol.81
, pp. 478-518
-
-
Dykewicz, M.S.1
Fineman, S.2
-
26
-
-
85120230370
-
-
Zyrtec [package insert]. New York, NY: Pfizer, Inc; 2000.
-
-
-
-
27
-
-
0032919046
-
Second-generation antihistamines: a comparative review
-
J.W. Slater A.D. Zechnich D.G. Haxby Second-generation antihistamines: a comparative review Drugs. 57 1999 31 47
-
(1999)
Drugs.
, vol.57
, pp. 31-47
-
-
Slater, J.W.1
Zechnich, A.D.2
Haxby, D.G.3
-
28
-
-
85120192774
-
-
Claritin [package insert]. Kenilworth, NJ: Schering-Plough; 2000.
-
-
-
-
29
-
-
0028882348
-
Loratadine administration concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluation
-
M.D. Brannan P. Reidenberg E. Radwanski Loratadine administration concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluation Clin Pharmacol Ther. 58 1995 269 278
-
(1995)
Clin Pharmacol Ther.
, vol.58
, pp. 269-278
-
-
Brannan, M.D.1
Reidenberg, P.2
Radwanski, E.3
|